One injection dropped LDL by 69 percent. Should we celebrate?
A new gene-editing therapy just dropped LDL cholesterol by 69 percent — with a single injection. One shot, permanent effect. Cue the headlines: “Game-changer!” “End of statins!” “Revolution in heart disease!”
Here we go again.
Let’s be clear: I’m not anti-innovation. I’m not against gene therapy. I’m against making the same mistake again and again, just with better marketing and shinier tools.
VERVE-102 is the latest miracle-in-a-vial — a CRISPR base-editing therapy that …